Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ALGN Stock Forecast 2026-2027
$167.74
Current Price
$12.01B
Market Cap
Buy 11
Hold 4
Sell 1
Wall St Analyst Ratings
Distance to ALGN Price Targets
+43.1%
To High Target of $240.00
+27.6%
To Median Target of $214.00
+4.3%
To Low Target of $175.00
ALGN Price Momentum
-4.1%
1 Week Change
-3.6%
1 Month Change
-7.1%
1 Year Change
+7.4%
Year-to-Date Change
-19.5%
From 52W High of $208.31
+37.5%
From 52W Low of $122.00
📊 TOP ANALYST CALLS
Did ALGN Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Align Technology is one of their latest high-conviction picks.
Latest ALGN Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, ALGN has a bullish consensus with a median price target of $214.00 (ranging from $175.00 to $240.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $167.74, the median forecast implies a 27.6% upside. This outlook is supported by 11 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ALGN Analyst Ratings
11
Buy
4
Hold
1
Sell
ALGN Price Target Range
Low
$175.00
Average
$214.00
High
$240.00
Current: $167.74
Latest ALGN Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ALGN.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 30, 2026 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $220.00 |
| Apr 24, 2026 | Morgan Stanley | Erin Wright | Equal-Weight | Maintains | $188.00 |
| Apr 21, 2026 | Piper Sandler | Overweight | Maintains | $N/A | |
| Apr 15, 2026 | Citigroup | Buy | Initiates | $N/A | |
| Mar 17, 2026 | Barclays | Overweight | Upgrade | $N/A | |
| Feb 26, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Feb 9, 2026 | HSBC | Buy | Upgrade | $N/A | |
| Feb 5, 2026 | Stifel | Buy | Maintains | $N/A | |
| Feb 5, 2026 | Piper Sandler | Overweight | Maintains | $N/A | |
| Feb 5, 2026 | UBS | Neutral | Maintains | $N/A | |
| Feb 5, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Feb 5, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Feb 5, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Jan 20, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Dec 9, 2025 | Barclays | Equal-Weight | Initiates | $N/A | |
| Oct 30, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Oct 30, 2025 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Oct 30, 2025 | Wells Fargo | Overweight | Maintains | $N/A | |
| Oct 30, 2025 | Piper Sandler | Overweight | Reiterates | $N/A | |
| Oct 21, 2025 | Morgan Stanley | Equal-Weight | Maintains | $N/A |
Align Technology, Inc. (ALGN) Competitors
The following stocks are similar to Align Technology based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Align Technology, Inc. (ALGN) Financial Data
Align Technology, Inc. has a market capitalization of $12.01B with a P/E ratio of 27.2x. The company generates $4.10B in trailing twelve-month revenue with a 10.5% profit margin.
Revenue growth is +6.2% quarter-over-quarter, while maintaining an operating margin of +16.6% and return on equity of +10.8%.
Valuation Metrics
Market Cap
$12.01B
Enterprise Value
$10.64B
P/E Ratio
27.2x
PEG Ratio
1.1x
Price/Sales
2.8x
Growth & Margins
Revenue Growth (YoY)
+6.2%
Gross Margin
+70.8%
Operating Margin
+16.6%
Net Margin
+10.5%
EPS Growth
+21.0%
Financial Health
Cash/Price Ratio
+8.8%
Current Ratio
1.4x
Debt/Equity
2.8x
ROE
+10.8%
ROA
+7.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Align Technology, Inc. (ALGN) Business Model
About Align Technology, Inc.
What They Do
Medical device company specializing in digital orthodontics.
Business Model
Align Technology generates revenue primarily through its clear aligner therapy, particularly the Invisalign product line, which is utilized by dental professionals to treat malocclusion. Additionally, the company earns income from its Systems and Services segment, offering iTero intraoral scanners and related software that enhance dental practice efficiency through digital solutions and integrated workflows.
Additional Information
Founded in 1997 and headquartered in Tempe, Arizona, Align Technology operates globally, catering to dental professionals in the healthcare and medical instruments and supplies sector. The company is positioned as a leader in the transition towards digital dentistry, emphasizing chairside and impressionless solutions that improve patient outcomes.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
20,275
CEO
Mr. Joseph M. Hogan
Country
United States
IPO Year
2001
Website
www.aligntech.comAlign Technology, Inc. (ALGN) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Is Omnicell Stock a Smart Addition to Your Portfolio Now?
OMCL rides on SaaS growth, Autonomous Pharmacy adoption and expansion plans, but rising costs and competition could test its momentum.
Jun 04, 2026
By Zacks Equity Research
Analyst Blog
ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge?
Illumina shares surge 98.7% in a year as NovaSeq X adoption accelerates, clinical sequencing demand grows, and the company tops Q1 2026 guidance.
Jun 03, 2026
By Zacks Equity Research
Analyst Blog
Medtronic Q4 Earnings and Revenues Beat, Stock Rises in Pre-Market
MDT tops Q4 revenue and earnings estimates as Cardiovascular strength and Cardiac Ablation growth fuel results, while FY27 guidance points higher.
Jun 03, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
Align Technology highlighted its digital dentistry platform at a William Blair investor presentation, showcasing Invisalign's role in consumer engagement, scanning, treatment planning, monitoring, and retention.
Why It Matters
Align Technology's focus on a comprehensive digital dentistry platform enhances its competitive edge, potentially boosting market share and driving future revenue growth for investors.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Align Technology, Inc. presented at the 46th Annual William Blair Growth Stock Conference, providing insights into its business and growth strategies.
Why It Matters
Align Technology's presentation at a major conference signals potential growth insights and strategic direction, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Align Technology, Inc. awarded twelve research grants to universities as part of its fifteenth Annual Research Award Program, emphasizing its commitment to research in digital orthodontics and dentistry.
Why It Matters
Align Technology's investment in research grants enhances its innovation pipeline, potentially leading to new products and increased market share, which can positively impact revenue and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Align Technology (ALGN) reported earnings 30 days ago; investors should monitor upcoming developments for insights on stock performance and future guidance.
Why It Matters
Align Technology's recent earnings report can indicate future stock performance, influencing investor sentiment and market trends, impacting decisions on buying or selling shares.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Align Technology (NASDAQ: ALGN) executives identified product innovation, financing initiatives, and international expansion as key growth drivers at the 2026 Stifel Jaws & Paws Conference.
Why It Matters
Align Technology's focus on product innovation, financing, and international expansion signals potential revenue growth, which may attract investor interest and boost stock performance.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
Align Technology, Inc. (ALGN) presented at the Stifel Jaws & Paws Conference, discussing company updates and strategies for future growth.
Why It Matters
Align Technology's presentation at a major conference signals potential insights into future growth, product developments, and market strategies, impacting investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About ALGN Stock
What is Align Technology, Inc.'s (ALGN) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, Align Technology, Inc. (ALGN) has a median price target of $214.00. The highest price target is $240.00 and the lowest is $175.00.
Is ALGN stock a good investment in 2026?
According to current analyst ratings, ALGN has 11 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $167.74. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ALGN stock?
Wall Street analysts predict ALGN stock could reach $214.00 in the next 12 months. This represents a 27.6% increase from the current price of $167.74. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Align Technology, Inc.'s business model?
Align Technology generates revenue primarily through its clear aligner therapy, particularly the Invisalign product line, which is utilized by dental professionals to treat malocclusion. Additionally, the company earns income from its Systems and Services segment, offering iTero intraoral scanners and related software that enhance dental practice efficiency through digital solutions and integrated workflows.
What is the highest forecasted price for ALGN Align Technology, Inc.?
The highest price target for ALGN is $240.00 from at , which represents a 43.1% increase from the current price of $167.74.
What is the lowest forecasted price for ALGN Align Technology, Inc.?
The lowest price target for ALGN is $175.00 from at , which represents a 4.3% increase from the current price of $167.74.
What is the overall ALGN consensus from analysts for Align Technology, Inc.?
The overall analyst consensus for ALGN is bullish. Out of 3 Wall Street analysts, 11 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $214.00.
How accurate are ALGN stock price projections?
Stock price projections, including those for Align Technology, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 6, 2026 2:04 AM UTC